Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2024Journal of Clinical Oncology

Impact of urolithin A supplementation, a mitophagy activator on mitochondrial health of immune cells (MitoIMMUNE): A randomized, double-blind, placebo-controlled trial in healthy adults.

View Full Paper
Ask AI
Bookmark
Share

Authors

DDDominic DenkASAnurag SinghHKHerbert G. Kasler

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Denk et al. (2024) studied this question.

synapsesocial.com/papers/68e66b2fb6db6435875f6ad3https://doi.org/10.1200/jco.2024.42.16_suppl.e14562
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A76-04 Mitophagy Activator Urolithin A Attenuates Lung Cell Injury2026
  2. 2Urolithin a modulates inter-organellar communication via calcium-dependent mitophagy to promote healthy ageing.2025 · 28 citations
  3. 3Evaluating the Impact of Urolithin A Supplementation on Running Performance, Recovery, and Mitochondrial Biomarkers in Highly Trained Male Distance Runners2025 · 9 citations
  4. 4Evaluation of Urolithin A Efficacy in Heart Failure Patients with Reduced Ejection Fraction: A Randomized, Double-blind, Crossover, Placebo-controlled Clinical Trial2024 · 5 citations
  5. 5Urolithin A improves Alzheimer's disease cognition and restores mitophagy and lysosomal functions2024 · 138 citations